Rifapentine is a rifamycin-class antibiotic primarily used in the treatment of pulmonary tuberculosis and latent tuberculosis infection. By inhibiting bacterial DNA-dependent RNA polymerase, this potent… Read more












Rifapentine is a rifamycin-class antibiotic primarily used in the treatment of pulmonary tuberculosis and latent tuberculosis infection. By inhibiting bacterial DNA-dependent RNA polymerase, this potent agent effectively prevents bacterial replication. In pharmaceutical development and quality control, access to high-quality reference standards is essential for the accurate assessment of drug safety and efficacy. This category includes a comprehensive range of analytical tools, such as identified process-related impurities and metabolites like 25-desacetyl rifapentine, which are critical for rigorous impurity profiling. Additionally, stable isotope-labelled compounds are provided to serve as internal standards in mass spectrometry-based analytical testing. These reference materials support laboratories in method validation, stability studies, and the monitoring of batch consistency, ensuring that analytical results meet stringent regulatory standards for the identification and quantification of rifapentine and its related substances.